Drug Shortage Report for SANDOZ LOSARTAN HCT DS
Report ID | 145303 |
Drug Identification Number | 02313383 |
Brand name | SANDOZ LOSARTAN HCT DS |
Common or Proper name | LOSARTAN HCT DS SDZ 100+25MG 100FCTBO CA |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 25MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100FCT BO |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2021-09-03 |
Estimated end date | 2022-12-09 |
Actual end date | 2022-12-07 |
Shortage status | Resolved |
Updated date | 2022-12-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-12-11 | French | Compare |
v8 | 2022-12-11 | English | Compare |
v7 | 2022-10-26 | French | Compare |
v6 | 2022-10-26 | English | Compare |
v5 | 2021-09-08 | French | Compare |
v4 | 2021-09-08 | English | Compare |
v3 | 2021-09-08 | French | Compare |
v2 | 2021-09-08 | English | Compare |
v1 | 2021-09-08 | English | Compare |
Showing 1 to 9 of 9